Anti-viral compounds

US11952365B2 · kind B2 · utility

Assignees

• Aligos Therapeutics, Inc. · US
• Katholieke Universiteit Leuven · BE

Inventors

• Koen Vandyck · Beringen, BE
• Pierre Jean-Marie Bernard Raboisson · Sligo, IE
• Leonid Beigelman · San Mateo, US
• Vladimir Serebryany · Burlingame, US
• Antitsa Dimitrova Stoycheva · Rue de l'Église, US
• Dorothée Alice Marie-Eve Bardiot · Leuven, BE
• Sandro Boland · Diepenbeek, BE
• Arnaud Marchand · Leuven, BE

Key dates

• Filing date: Jun 8, 2021
• Grant date: Apr 9, 2024
• Expiry date: Oct 24, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F9/65583
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.